Breaking News Instant updates and real-time market news.

RHHBY

Roche

$30.06

(0.00%)

15:27
02/15/18
02/15
15:27
02/15/18
15:27

Roche to acquire Flatiron Health in $1.9B deal

Roche and Flatiron Health announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health, following on from an existing equity stake of 12.6%. The transaction is expected to close in the first half of 2018. Under the terms of the agreement, Roche will make a payment of $1.9B to Flatiron Health on a fully diluted basis, subject to certain adjustments. The closing of the transaction is subject to customary closing conditions. The parties expect that following the closing, Flatiron Health will continue its current business model, network of partnerships and overall objectives. The integrity of segregated patient protected health information will be preserved, as will dedicated sales and marketing, provider-facing and life science business activities.

  • 23

    Feb

  • 30

    May

RHHBY Roche
$30.06

(0.00%)

02/12/18
LEER
02/12/18
NO CHANGE
Target $502
LEER
Outperform
Data from Regeneron Eylea competitors should lift some overhang, says Leerink
Leerink analyst Geoffrey Porges says that the "confusing and somewhat lackluster data" presented over the weekend for Eylea's theoretical competitors should lift some of the overhang that Regeneron's stock has suffered from over the last 6 months. Novartis' (NVS) brolucizumab pivotal trial is confusing, and the data incomplete, and the analyst has serious doubts about the drug's approvability. Secondly, the addition of Ang2 inhibition to VEGF inhibition, while theoretically intriguing, has so far been of modest benefit despite Roche's (RHHBY) posturing, he contends. Porges reiterates an Outperform rating and $502 price target on Regeneron's shares.
02/08/18
02/08/18
DOWNGRADE

Neutral
Regeneron downgraded to Neutral ahead of Roche readout at BTIG
As previously reported, BTIG analyst Dane Leone downgraded Regeneron (REGN) to Neutral from Buy, stating that he is optimistic that Roche's (RHHBY) coming read-out of the BOULEVARD study may show encouraging clinical results on Feb 13 to support a pivotal effort and may show VEGF + ANG2 inhibition may provide incremental benefits over VEGF therapy alone in DME and potentially wetAMD. He also noted that REGN1979 bi-specific has shown limited efficacy in patients with Agg-NHL.
02/05/18
JEFF
02/05/18
NO CHANGE
Target $25
JEFF
Hold
Acorda remains takeover candidate after competitor data, says Jefferies
Jefferies analyst Michael Yee believes the positive Phase III topline results from Acorda Therapeutics (ACOR) competitor Sunovion for APL-130277 in Parkinson's patients came in as expected. While APL-130277 data compares favorably over Inbrija's 3.92 point difference at week 12, Yee cautions to compare directly head-to-head since patient baseline characteristics could be different. Acorda remains a "reasonably likely" acquisition candidate in 2018 given its $300M-$500M-plus Parkinson's asset Inbrija, Yee tells investors in a research note. The analyst does not think Biogen (BIIB) should buy the company, but sees other potential suitors in AbbVie (ABBV), Allergan (AGN), Mitsubishi, Roche (RHHBY) and Shire (SHPG). He believes a takeover price could be north of $2B. Yee keeps a Hold rating on Acorda with a $25 price target.
01/15/18
SOCG
01/15/18
DOWNGRADE
SOCG
Sell
Roche downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Justin Smith downgraded Roche to Sell and cut his price target for the shares to CHF 190 from CHF 250.The analyst sees downside risk to consensus estimates from generic competition and expects the stock to underperform.

TODAY'S FREE FLY STORIES

HIBB

Hibbett Sports

$18.04

-0.46 (-2.49%)

06:31
03/22/19
03/22
06:31
03/22/19
06:31
Hot Stocks
Breaking Hot Stocks news story on Hibbett Sports »

Hibbett Sports reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

HIBB

Hibbett Sports

$18.04

-0.46 (-2.49%)

06:30
03/22/19
03/22
06:30
03/22/19
06:30
Earnings
Hibbett Sports reports Q4 adjusted EPS 57c, consensus 39c »

Reports Q4 revenue $306M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

CMC

Commercial Metals

$17.35

1.29 (8.03%)

06:29
03/22/19
03/22
06:29
03/22/19
06:29
Upgrade
Commercial Metals rating change  »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$25.82

2.915 (12.73%)

06:28
03/22/19
03/22
06:28
03/22/19
06:28
Recommendations
Conagra Brands analyst commentary  »

Conagra Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$109.79

1.83 (1.70%)

, AMZN

Amazon.com

$1,818.45

21.09 (1.17%)

06:27
03/22/19
03/22
06:27
03/22/19
06:27
Periodicals
UPS prepares to test U.S. in-home vaccine service, Reuters reports »

United Parcel Service…

UPS

UPS

$109.79

1.83 (1.70%)

AMZN

Amazon.com

$1,818.45

21.09 (1.17%)

MRK

Merck

$82.94

0.85 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 04

    Apr

  • 11

    Apr

  • 25

    Apr

  • 30

    Apr

  • 18

    May

  • 17

    Jun

CHL

China Mobile

06:26
03/22/19
03/22
06:26
03/22/19
06:26
Downgrade
China Mobile rating change  »

China Mobile downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$208.00

2.78 (1.35%)

06:25
03/22/19
03/22
06:25
03/22/19
06:25
Recommendations
Cintas analyst commentary  »

Cintas price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$430.32

0.35 (0.08%)

06:24
03/22/19
03/22
06:24
03/22/19
06:24
Periodicals
BlackRock advances talks to buy French software provider eFront, WSJ says »

The Wall Street…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

SHW

Sherwin-Williams

$433.70

4.385 (1.02%)

06:23
03/22/19
03/22
06:23
03/22/19
06:23
Downgrade
Sherwin-Williams rating change  »

Sherwin-Williams…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

CNAT

Conatus

$2.91

0.02 (0.69%)

06:22
03/22/19
03/22
06:22
03/22/19
06:22
Downgrade
Conatus rating change  »

Conatus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$112.60

1.73 (1.56%)

06:21
03/22/19
03/22
06:21
03/22/19
06:21
Downgrade
PPG rating change  »

JPMorgan downgrades PPG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

TSLA

Tesla

$274.10

0.6 (0.22%)

06:21
03/22/19
03/22
06:21
03/22/19
06:21
Periodicals
Tesla's Musk calls vehicle deliveries 'primary priority', Reuters reports »

Tesla CEO Elon Musk told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$52.05

2.395 (4.82%)

, AAPL

Apple

$195.07

6.93 (3.68%)

06:18
03/22/19
03/22
06:18
03/22/19
06:18
Upgrade
Lumentum, Apple rating change  »

JPMorgan upgrades…

LITE

Lumentum

$52.05

2.395 (4.82%)

AAPL

Apple

$195.07

6.93 (3.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    May

SHLD

Sears

$0.00

(0.00%)

06:15
03/22/19
03/22
06:15
03/22/19
06:15
Periodicals
Judge warns Lampert's firm to return money to Sears, NY Post says »

According to the NY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$54.05

1.41 (2.68%)

06:15
03/22/19
03/22
06:15
03/22/19
06:15
Periodicals
Oracle quietly laid off employees this week, Business Insider reports »

Oracle quietly held a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$46.15

0.915 (2.02%)

06:14
03/22/19
03/22
06:14
03/22/19
06:14
Initiation
Energizer initiated  »

Energizer initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$88.05

1.3597 (1.57%)

06:10
03/22/19
03/22
06:10
03/22/19
06:10
Recommendations
Nike analyst commentary  »

Nike investments paying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 04

    Apr

BRN

Barnwell Industries

$1.30

(0.00%)

06:10
03/22/19
03/22
06:10
03/22/19
06:10
Hot Stocks
Barnwell Industries announces real estate transaction through KD »

Barnwell Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$48.95

2.73 (5.91%)

, HPE

HP Enterprise

$16.03

0.15 (0.94%)

06:09
03/22/19
03/22
06:09
03/22/19
06:09
Periodicals
Seagate teams up with HPE, Nvidia for Project Athena, DigiTimes reports »

Seagate (STX) has…

STX

Seagate

$48.95

2.73 (5.91%)

HPE

HP Enterprise

$16.03

0.15 (0.94%)

NVDA

Nvidia

$183.92

9.54 (5.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

ESALY

Eisai

$0.00

(0.00%)

06:06
03/22/19
03/22
06:06
03/22/19
06:06
Downgrade
Eisai rating change  »

Eisai downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVA

Covanta

$17.04

0.27 (1.61%)

06:05
03/22/19
03/22
06:05
03/22/19
06:05
Hot Stocks
Covanta, Green Investment Group reach financial close on Rookery project »

Covanta and Green…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

GBX

Greenbrier

$37.33

0.45 (1.22%)

06:05
03/22/19
03/22
06:05
03/22/19
06:05
Earnings
Greenbrier reports preliminary Q2 EPS 7c-9c, consensus 42c »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$166.08

0.61 (0.37%)

06:05
03/22/19
03/22
06:05
03/22/19
06:05
Periodicals
Facebook knew about data misuse earlier than reported, Guardian says »

Facebook knew about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

NKE

Nike

$88.05

1.3597 (1.57%)

06:04
03/22/19
03/22
06:04
03/22/19
06:04
Recommendations
Nike analyst commentary  »

Nike price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 04

    Apr

GTLS

Chart Industries

$94.49

2.06 (2.23%)

, BHGE

Baker Hughes

$28.50

0.24 (0.85%)

06:03
03/22/19
03/22
06:03
03/22/19
06:03
Hot Stocks
Chart Industries books $135M order »

Chart Industries (GTLS)…

GTLS

Chart Industries

$94.49

2.06 (2.23%)

BHGE

Baker Hughes

$28.50

0.24 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 22

    May

  • 28

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.